Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DR1YQ7
|
|||
| Drug Name |
GEN-011
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 1 | [1] | |
| Non-small-cell lung cancer [ICD-11: 2C25] | Phase 1 | [1] | ||
| Squamous head and neck cell carcinom [ICD-11: 2D60.0; ICD-10: C77.0] | Phase 1 | [1] | ||
| Company |
Genocea Biosciences
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04596033) TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.